Risk Factors for Urinary Tract Infection in Gynecological Malignant Tumor Inpatients: A Retrospective Study
Abstract
Objective Urinary tract infection (UTI) is one of the most common infectious complications in hospitalized patients with gynecological malignancies and may lead to treatment interruption, prolonged hospitalization, increased healthcare costs, and even severe systemic infection. To investigate the incidence of UTI and identify its associated risk factors among hospitalized patients with gynecological malignancies at Meizhou People’s Hospital, in order to provide evidence for targeted prevention and optimized clinical management. Methods This study conducted a retrospective analysis of 659 hospitalized patients with gynecological malignant tumors who were treated at Meizhou People’s Hospital in 2024. Clinical data were retrospectively collected, including general baseline data, tumor-related data, treatment-related data, and infection-related data. Univariate analysis and multivariate logistic regression analyses were used to screen the risk factors for UTI. Results In terms of tumor classification, cervical cancer accounted for the largest proportion, with 291 cases (44.2%), followed by endometrial carcinoma (201 cases, 30.5%), ovarian cancer (99 cases, 15.0%), and other types of gynecological malignancies (68 cases, 10.3%). Regarding treatment, 341 (51.7%) patients underwent ureteral stenting, 197 (29.9%) patients had an indwelling catheter for ≥7 days, 152 (23.1%) patients received chemotherapy, and 516 (78.3%) patients underwent surgical treatment. The incidence of UTI was…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.